TWI712425B - Skin physiotherapy formula of deep sea water concentrate for mature skin appearance improvement and the use thereof - Google Patents
Skin physiotherapy formula of deep sea water concentrate for mature skin appearance improvement and the use thereof Download PDFInfo
- Publication number
- TWI712425B TWI712425B TW107122672A TW107122672A TWI712425B TW I712425 B TWI712425 B TW I712425B TW 107122672 A TW107122672 A TW 107122672A TW 107122672 A TW107122672 A TW 107122672A TW I712425 B TWI712425 B TW I712425B
- Authority
- TW
- Taiwan
- Prior art keywords
- aforementioned
- agent
- fiber membrane
- concentrate
- skin
- Prior art date
Links
- 239000012141 concentrate Substances 0.000 title claims abstract description 59
- 238000000554 physical therapy Methods 0.000 title claims abstract description 37
- 239000013535 sea water Substances 0.000 title abstract description 20
- 230000037306 mature skin Effects 0.000 title abstract 2
- 239000012528 membrane Substances 0.000 claims abstract description 57
- 239000000835 fiber Substances 0.000 claims abstract description 51
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 32
- 210000003491 skin Anatomy 0.000 claims description 49
- 102000008186 Collagen Human genes 0.000 claims description 14
- 108010035532 Collagen Proteins 0.000 claims description 14
- 229920001436 collagen Polymers 0.000 claims description 14
- 239000002537 cosmetic Substances 0.000 claims description 11
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 7
- 239000011707 mineral Substances 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000011777 magnesium Substances 0.000 claims description 6
- 229910052749 magnesium Inorganic materials 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 230000003796 beauty Effects 0.000 claims description 5
- 210000004207 dermis Anatomy 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 5
- 210000002374 sebum Anatomy 0.000 claims description 5
- 230000005611 electricity Effects 0.000 claims description 4
- 230000035755 proliferation Effects 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 3
- 230000005484 gravity Effects 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- 230000000638 stimulation Effects 0.000 claims description 3
- 230000002087 whitening effect Effects 0.000 claims description 3
- 230000003750 conditioning effect Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 description 16
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 10
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 10
- 206010040954 Skin wrinkling Diseases 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 102100030416 Stromelysin-1 Human genes 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 108010016160 Matrix Metalloproteinase 3 Proteins 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 201000003004 ptosis Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- JIRXORZYIXSWOB-UHFFFAOYSA-N n-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]acetamide Chemical compound COC1=CC=C(S(=O)(=O)N(CC(C)C)CC(=O)NO)C=C1 JIRXORZYIXSWOB-UHFFFAOYSA-N 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 210000004709 eyebrow Anatomy 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- VKUYLANQOAKALN-UHFFFAOYSA-N 2-[benzyl-(4-methoxyphenyl)sulfonylamino]-n-hydroxy-4-methylpentanamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(C(CC(C)C)C(=O)NO)CC1=CC=CC=C1 VKUYLANQOAKALN-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 101710108790 Stromelysin-1 Proteins 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- -1 but not limited to Substances 0.000 description 2
- 244000221110 common millet Species 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 101000573882 Coccidioides posadasii (strain C735) Neutral protease 2 homolog MEP3 Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 101710180313 Protease 3 Proteins 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MMDJDBSEMBIJBB-UHFFFAOYSA-N [O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[NH6+3] Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[NH6+3] MMDJDBSEMBIJBB-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000010909 chemical acidification Methods 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
本發明係有海洋深層濃縮物皮膚理療配方用於改善皮膚樣貌的應用及方法;其步驟包括提供一海洋深層濃縮物、一皮膚用理療配方與一纖維膜,並施於一患部表面,且特別有關於搭配使用一導入儀進行施用。 The present invention is an application and method of a skin physiotherapy formula of deep sea concentrate for improving skin appearance; the steps include providing a deep sea concentrate, a skin physiotherapy formula and a fiber membrane, and applying them to the surface of an affected area, and It is especially related to the use of a lead-in instrument for application.
海洋深層水(deep-sea water,DSW)是取自低於海平面200公尺以下之低溫、潔淨無污染的海水,其特性包含:(1)潔淨性:深層海水與表層海水不同,深層海水不受人為污染的影響,表層海水在沉澱過程中,細菌會因化學酸化、沉澱、移流擴散等分解作用,且會隨深度而逐漸減少。因深海無殘存細菌所需的有機物質沉澱且不含硝酸體氮素之供給,細菌難以繁殖。因此,導致病變的各種有害細菌或病菌,在深層海水中的含量均極為稀少,僅為表層水的千分之一至萬分之一。再者,殘存於深層海水的有機物,對微生物分解殘渣有機物作用的抵抗性相當安定,這也是深 層海水水質在微生物學或物理化學方面較為安定、無機且清淨的原因。(2)低溫性:由於太陽光線無法照到深層海水,所以水溫較表層海水低,且溫度較無明顯的變化,終年維持低溫穩定狀態。(3)富無機營養鹽:由於深層海水光線不足,生物無法進行光合作用,因此植物性浮游生物所需的必要營養鹽一氮、磷、矽、硝酸等都無法消耗,大量累積在深層海水中。(4)熟成安定性:處於高壓與大氣隔絶的影響,使深層海水長年成份穩定。(5)富礦物質性:海洋中的礦物質主要來岩層,經雨水沖刷至海洋,形成水溶性礦物質,均勻分佈在海水中。。 Deep-sea water (DSW) is taken from low-temperature, clean and pollution-free sea water below
近幾年,海洋深層水已被廣泛應用於食品加工業、農業、與藥用。有研究文獻指出海洋深層水能降低血脂肪、脂質氧化、血管硬化與高血壓,同時也能減少血管管壁增生;雖然在異位性皮膚炎的研究上,也發現病患在飲用或浸泡深層海水後能改善皮膚發炎與過敏的症狀、然並未大規模應用於化妝品產業。此外,飲用海洋深層水也被發現能用於改善白內障。並已有文獻指出,於細胞實驗中發現、海洋深層水可刺激膠原蛋白新生,使肌膚美白,抑制或治療發炎的現象 In recent years, deep ocean water has been widely used in food processing industry, agriculture, and medicine. Some research literature points out that deep ocean water can reduce blood fat, lipid oxidation, vascular sclerosis and hypertension, as well as vascular wall hyperplasia; although in the research of atopic dermatitis, it is also found that patients are drinking or soaking deep Sea water can improve skin inflammation and allergies, but it has not been widely used in the cosmetics industry. In addition, drinking deep ocean water has also been found to be used to improve cataracts. It has also been pointed out in the literature that it has been found in cell experiments that deep ocean water can stimulate the regeneration of collagen, whiten the skin, and inhibit or treat inflammation.
市售各類化妝品或保養品因屬於大分子且海洋深層濃縮物具高表面張力,因此不易被皮膚吸收。再者,保養品和化妝品混合海洋深層濃縮液或海洋深層水放置一段時間後會變質。所以保養品和化妝品混合海洋深層濃縮液或海洋深層水後不宜放置太久,而本發明提供一種海洋深層濃縮物皮膚理療配方施用於患部上的方法,可以解決上述問題,並使保 養品與海洋深層濃縮物快速地穿透皮脂膜,達到真皮層,使患者的外觀及樣貌有所改善。 Various types of cosmetics or skin care products on the market are not easily absorbed by the skin because they are macromolecules and deep-sea concentrates have high surface tension. Furthermore, skin care products and cosmetics mixed with deep-sea concentrate or deep-sea water will deteriorate after a period of time. Therefore, skin care products and cosmetics should not be left for too long after being mixed with deep ocean concentrate or deep ocean water. The present invention provides a method for applying deep ocean concentrate skin physiotherapy formula to the affected area, which can solve the above problems and make the skin care products compatible with the ocean. The deep concentrate quickly penetrates the sebum membrane and reaches the dermis, improving the patient's appearance and appearance.
有鑑於此,本發明係提供一種海洋深層濃縮物皮膚理療配方用於改善老化樣貌的應用及方法。且本發明之海洋深層濃縮物皮膚理療配方的特徵在於其具有立即微粒化皮膚用理療配方、立即減少海洋深層濃縮物高表面張力,解決皮膚不易吸收的問題以及海洋深層濃縮物的物質特性能,成為微粒化後的皮膚用理療配方滲透的推動力(Driving Force),並搭配導入儀使用,可使皮膚理療配方的快速地進入穿透皮脂膜,達到真皮層,並達到減緩膠原蛋白流失、達到抗衰老的效果。 In view of this, the present invention provides an application and method of deep-sea concentrate skin physiotherapy formula for improving aging appearance. Moreover, the skin physiotherapy formula of deep sea concentrate of the present invention is characterized in that it has a physiotherapy formula for immediate micronization of the skin, immediately reduces the high surface tension of the deep sea concentrate, solves the problem of difficult skin absorption and the material characteristics of the deep sea concentrate, It becomes the driving force for the penetration of the micronized skin with the physiotherapy formula, and when used with the introduction device, the skin physiotherapy formula can quickly penetrate the sebum membrane, reach the dermis, and slow down the loss of collagen. Anti-aging effect.
本發明提供一種海洋深層濃縮物皮膚理療配方之使用方法,其步驟包括:(a)提供一第一劑,其中該第一劑係為海洋深層濃縮物;(b)提供一第二劑,其中該第二劑係為皮膚用理療配方;(c)提供一纖維膜,將該纖維膜先浸潤於該第二劑再浸潤於該第一劑,形成一浸潤纖維膜;(d)將該浸潤纖維膜立即敷貼於一患部表面;(e)施用一導入儀於該浸潤纖維膜上,該導入儀每平方公分施用之電流為0.1mA~0.8mA,每平方公分施用之時間為15~30秒;其中,透過該步驟(e)使該第一劑與該第二劑快速地穿透皮脂膜達到真皮層,並達到刺激膠原蛋白增生。 The present invention provides a method for using a deep-sea concentrate skin physiotherapy formula, the steps of which include: (a) providing a first agent, wherein the first agent is a deep ocean concentrate; (b) providing a second agent, wherein The second agent is a physiotherapy formula for skin; (c) a fiber membrane is provided, and the fiber membrane is first infiltrated in the second agent and then in the first agent to form an infiltrating fiber membrane; (d) the infiltration The fiber membrane is immediately applied to the surface of an affected area; (e) an introducer is applied to the infiltrated fiber membrane, the current applied by the introducer is 0.1mA~0.8mA per square centimeter, and the application time per square centimeter is 15-30 Seconds; wherein, through the step (e), the first agent and the second agent can quickly penetrate the sebum membrane to reach the dermis, and stimulate collagen proliferation.
較佳地,其中於該浸潤纖維膜中,該第一劑的有效濃度至 少大於或等於1.25(v/v)%。 Preferably, the effective concentration of the first agent in the infiltrated fiber membrane is at least greater than or equal to 1.25 (v/v)%.
較佳地,其中步驟d)中,該浸潤纖維膜於10分鐘內施用於該患部。 Preferably, in step d), the infiltrated fiber membrane is applied to the affected part within 10 minutes.
較佳地,其中步驟e)中,於10分鐘內施用該導入儀於該浸潤纖維膜上。 Preferably, in step e), the introduction instrument is applied to the infiltrated fiber membrane within 10 minutes.
較佳地,其中該患部為臉部、手臂、腹部或腿部。 Preferably, the affected part is the face, arm, abdomen or leg.
較佳地,該導入儀施用的電流,因患部使用纖維膜大小及位置不同,為0.1mA~0.8mA/cm2,施作時間為患部貼膜15~30秒/cm2。 Preferably, the current applied by the introduction device is 0.1mA~0.8mA/cm 2 due to the size and position of the fiber membrane used in the affected area, and the application time is 15-30 seconds/cm 2 of the affected area.
較佳地,其中該第一劑之鎂濃度為6,500~110,000mg/l、鈉濃度為3,800~30,000mg/l、鉀濃度為400~18,000mg/l、鈣濃度為100~500mg/l。硬度為80,000~420,000mg/l,鹽度為380~430‰。該第一劑每100g中含有1000~1500mg的鈣、1400~2100mg鎂、2000~4000mg的鈉、1400~2100mg的鉀、硫酸根<6.5wt%,且比重為1.17~1.32g/cm3之海洋礦物質之溶液。較佳地,該第一劑取自海洋200m以下之水源;較佳地,該第一劑取自海洋500m以下之水源。較佳地,該第一劑為液體或粉體。 Preferably, the magnesium concentration of the first dose is 6,500-110,000 mg/l, the sodium concentration is 3,800-30,000 mg/l, the potassium concentration is 400-18,000 mg/l, and the calcium concentration is 100-500 mg/l. The hardness is 80,000~420,000mg/l, and the salinity is 380~430‰. The first dose contains 1000~1500mg calcium, 1400~2100mg magnesium, 2000~4000mg sodium, 1400~2100mg potassium, sulfate <6.5wt% per 100g, and the specific gravity is 1.17~1.32g/cm 3 ocean Mineral solution. Preferably, the first agent is taken from a water source below 200 m in the ocean; preferably, the first agent is taken from a water source below 500 m in the ocean. Preferably, the first agent is liquid or powder.
較佳地,其中該第二劑係為抗老、拉提、緊緻、美白、保濕、醫學或美容導入用品、促進膠原蛋白增生產品。較佳地,該第二劑為凝膠狀。。 Preferably, the second agent is an anti-aging, lifting, firming, whitening, moisturizing, medical or cosmetic introduction product, and a product for promoting collagen proliferation. Preferably, the second agent is gel-like. .
較佳地,該導入儀係包含一給電裝置與一傳感器,前述給 電裝置包含一外表面及一內裝;其中,前述給電裝置之外表面包含:一操作面板,其設置於前述理療儀之一側面,藉以提供一控制指令,調控前述給電裝置所輸出之一直流電,前述直流電係由不同強度與不同時間比例的正負電所組合;一傳感器連接孔,藉以外接前述傳感器,前述傳感器連接孔更具有一稳定电流侦測電路,係電連一控制電路以及前述傳感器連接孔,用以放大一刺激電流之電壓;以及一電源輸入端,設置於前述理療儀另一側面,藉以提供前述給電裝置一電源,前述電源輸入端更具有複數安全電路,係電連前述控制電路以及前述電源輸入端,用以控制前述電源之不同電壓;其中,前述給電裝置之內裝具有前述控制電路,係電連前述操作面板取得前述控制指令以及前述電源輸入端取得前述電源供應,並經由前述傳感器連接孔輸出前述直流電,包含:一固定實測人體電路,用以控制前述直流電之不同強度;以及一開關閥電路,係經由前述控制指令選擇,控制前述直流電之正負電;其中,前述傳感器係指以一電線外接前述給電裝置之前述傳感器連接孔,其具有一特定面積介面的放電端,使前述直流電經由前述傳感器輸出前述刺激電流。 Preferably, the induction device includes a power feeding device and a sensor. The power feeding device includes an outer surface and an interior; wherein, the outer surface of the power feeding device includes: an operation panel disposed on one of the aforementioned physical therapy devices On the side, a control command is provided to regulate a direct current output from the aforementioned power supply device. The aforementioned direct current is a combination of positive and negative electricity of different strengths and different time ratios; a sensor connection hole for connecting the aforementioned sensor, the aforementioned sensor connection hole further has A stable current detection circuit is electrically connected to a control circuit and the aforementioned sensor connection hole for amplifying the voltage of a stimulating current; and a power input terminal is arranged on the other side of the aforementioned physical therapy device to provide a power source for the aforementioned electrical device The aforementioned power input terminal further has a plurality of safety circuits, which are electrically connected to the aforementioned control circuit and the aforementioned power input terminal to control the different voltages of the aforementioned power source; wherein, the aforementioned power supply device is equipped with the aforementioned control circuit, which is electrically connected to the aforementioned operation The panel obtains the aforementioned control commands and the aforementioned power input terminal obtains the aforementioned power supply, and outputs the aforementioned direct current through the sensor connection hole, including: a fixed actual body circuit for controlling the different intensities of the aforementioned direct current; and an on-off valve circuit through The aforementioned control command selects to control the positive and negative electricity of the aforementioned direct current; wherein, the aforementioned sensor refers to the aforementioned sensor connection hole of the aforementioned power supply device with a wire connected to it, which has a discharge terminal with a specific area interface, so that the aforementioned direct current outputs the aforementioned stimulus through the aforementioned sensor Current.
較佳地,該導入儀施用的電流為2mA~25mA,較佳地,根據纖維膜大小改變電流,每平方公分施用電流0.1~0.8mA,施作時間為患部纖維膜15~30秒/cm2。 Preferably, the current is introduced into the apparatus administered 2mA ~ 25mA, preferably, fiber membrane according to the magnitude of the current change, a current per square centimeter administered 0.1 ~ 0.8mA, applied to the affected area as time fiber membrane 15 to 30 seconds / c m2 .
較佳地,根據該纖維膜的大小,該第二劑的使用量為每平方公分0.4克。 Preferably, according to the size of the fiber membrane, the usage amount of the second agent is 0.4 grams per square centimeter.
為達到上述及其它目的,以下對本發明一或多個具體實施例進行說明。本發明的其它特徵或優點以實施例及請求項詳細描述。 To achieve the foregoing and other objectives, one or more specific embodiments of the present invention will be described below. Other features or advantages of the present invention are described in detail with embodiments and claims.
125‧‧‧安全電路 125‧‧‧Safety circuit
126‧‧‧固定實測人體電路 126‧‧‧Fixed measured human body circuit
127‧‧‧穩定電流偵測電路 127‧‧‧Stable current detection circuit
第1圖係為人體臉部老化樣貌變化示意圖。 Figure 1 is a schematic diagram of changes in the aging appearance of the human face.
第2A-2C圖顯示本發明之使用方法於眼部之使用前後比較圖,眼部的變化。第2A圖為使用前,第2B圖為使用後,第2C圖為使用後一天。使用後黑眼圈、魚尾紋 Figures 2A-2C show the comparison of the use method of the present invention before and after the use of the eyes, and the changes in the eyes. Picture 2A is before use, picture 2B is after use, and picture 2C is one day after use. Dark circles and crow's feet after use
第2D-2F圖顯示本發明之使用方法於眼部之使用前後比較圖,眼部的變化。第2D圖為使用前,第2E圖為使用後,第2F圖為使用後一天。 Figures 2D-2F show the comparison of the use method of the present invention before and after the use of the eyes, and the changes in the eyes. Picture 2D is before use, Picture 2E is after use, Picture 2F is one day after use.
第3A-3C圖顯示本發明之使用方法於臉部之使用前後比較圖,法令紋及木偶紋的變化。第3A圖為使用前,第3B圖為使用後第四天,第3C圖為使用後第五天。 Figures 3A-3C show the comparison of the use method of the present invention before and after the use of the face, the changes in the law pattern and the marionette pattern. Picture 3A is before use, picture 3B is the fourth day after use, and picture 3C is the fifth day after use.
第3D、3E圖顯示本發明之使用方法於臉部之使用前後比較圖,法令紋及木偶紋的變化。第3D圖為使用前,第3E圖為使用後。 Figures 3D and 3E show the comparison of the use method of the present invention before and after the use of the face, and the changes of the law pattern and the puppet pattern. Picture 3D is before use, Picture 3E is after use.
第4A-4B圖顯示本發明之使用方法於臉部之使用前後比較圖,頸部鬆弛(即雙下巴)的變化。第4A圖為使用前,第4B圖為使用後。 Figures 4A-4B show the comparison of the application method of the present invention on the face before and after use, and the changes in the looseness of the neck (ie double chin). Picture 4A is before use, Picture 4B is after use.
第5圖為導入儀控制電路示意圖 Figure 5 is a schematic diagram of the control circuit of the importer
第6A、6B圖為海洋深層濃縮物對於抑制基質金屬蛋白酶-1和基質金屬蛋白酶-3的酵素活性效果。 Figures 6A and 6B show the effect of deep ocean concentrate on inhibiting the enzyme activity of matrix metalloproteinase-1 and matrix metalloproteinase-3.
第7圖為海洋深層濃縮物對於增加分泌膠原蛋白的效果。 Figure 7 shows the effect of deep ocean concentrate on increasing the secretion of collagen.
本發明係提供一種海洋深層濃縮物皮膚理療配方用於改善外觀與樣貌的應用及方法。 The present invention provides an application and method for improving the appearance and appearance of a skin physiotherapy formula of deep ocean concentrate.
本發明中所述之“海洋深層水”係指取自海平面下200至1500公尺,較佳為海平面下500至700公尺的海水,每100g溶(液/粉)中含有1000~1500mg的鈣、1400~2100mg鎂、2000~4000mg的鈉、1400~2100mg的鉀、硫酸根<6.5wt%,且比重為1.17-1.32g/cm3之海洋礦物質之溶液。 The "deep ocean water" in the present invention refers to seawater taken from 200 to 1500 meters below sea level, preferably 500 to 700 meters below sea level, and each 100g of dissolved (liquid/powder) contains 1000~ 1500mg calcium, 1400-2100mg magnesium, 2000-4000mg sodium, 1400-2100mg potassium, sulfate <6.5wt%, and a specific gravity of 1.17-1.32g/cm 3 marine mineral solution.
本發明中所述之“海洋深層濃縮物”係指海洋深層水經濃縮程序後所產生的液體或粉體。此海洋深層濃縮(液/粉)濃縮程序使用纖維過濾系統、超過濾系統、海水逆滲透系統、低溫真空蒸發濃縮系統及/或離心等步驟。 The "deep ocean concentrate" mentioned in the present invention refers to the liquid or powder produced after the deep ocean water is concentrated. This deep ocean concentration (liquid/powder) concentration process uses fiber filtration systems, ultrafiltration systems, seawater reverse osmosis systems, low-temperature vacuum evaporation concentration systems and/or centrifugation.
海洋深層濃縮物之硬度為80,000~420,000mg/l、鹽度為380~430‰、鎂濃度為6,500~110,000mg/l及鈉濃度為3,800~30,000mg/l。本發明之海洋深層濃縮物富含多種礦物質,包括,但不限於,鈣(Ca)、鉀(K)、鐵(Fe)、鋅(Zn)、鉬(Mo)、錳(Mn)、鋰(Li)、鍶(Sr)、銅(Cu)、矽(Si)等微量元素。在一實施例中,海洋深層濃縮物的成分如表一所示,但由於檢測單位未將完整的元素檢測完成,所以本發明之海洋深層濃縮物不限於此。 The deep ocean concentrate has a hardness of 80,000~420,000mg/l, a salinity of 380~430‰, a magnesium concentration of 6,500~110,000mg/l and a sodium concentration of 3,800~30,000mg/l. The deep ocean concentrate of the present invention is rich in a variety of minerals, including, but not limited to, calcium (Ca), potassium (K), iron (Fe), zinc (Zn), molybdenum (Mo), manganese (Mn), lithium (Li), Strontium (Sr), Copper (Cu), Silicon (Si) and other trace elements. In one embodiment, the composition of the deep-sea concentrate is shown in Table 1, but since the testing unit has not completed the complete element detection, the deep-sea concentrate of the present invention is not limited to this.
表一、海洋深層濃縮物的成分
本發明中所述之“纖維膜”係指超細長纖維面膜。 The "fibrous membrane" in the present invention refers to an ultra-fine long-fibre facial mask.
本發明中所述之“浸潤纖維膜”係指浸潤於該皮膚理療配方 與該海洋深層濃縮物後的纖維膜,其係含有海洋深層濃縮物與皮膚理療配方的混合物。 The "infiltrated fiber membrane" in the present invention refers to the fiber membrane after being soaked in the skin physiotherapy formula and the deep ocean concentrate, which contains a mixture of the deep ocean concentrate and the skin physiotherapy formula.
本發明中所述之“皮膚理療配方”係指一般凝膠態配方產品及美容相關院所使用於療程的配方。例如,美白用品、保濕用品、除皺用品、傷口癒合用品、速癒療程等改善肌膚外觀的用品。 The "skin physiotherapy formula" mentioned in the present invention refers to general gel formula products and formulas used in treatment courses in beauty-related institutions. For example, whitening products, moisturizing products, wrinkle removal products, wound healing products, quick-healing treatments and other products that improve the appearance of the skin.
本發明之“海洋深層濃縮物與皮膚理療配方的混合物”或“第一劑與第二劑的混合物”係指纖維膜浸潤於該皮膚理療配方與該海洋深層濃縮物後,該海洋深層濃縮物會混合於該皮膚理療配方中,即纖維膜中會含有混合海洋深層濃縮物與皮膚理療配方的混合物體。 The "mixture of deep ocean concentrate and skin physiotherapy formula" or "mixture of first agent and second agent" in the present invention refers to the deep ocean concentrate after the fibrous membrane is soaked in the skin physiotherapy formula and the deep ocean concentrate It will be mixed in the skin physiotherapy formula, that is, the fiber membrane will contain a mixture of deep ocean concentrate and skin physiotherapy formula.
然而,海洋深層濃縮物混合至皮膚理療配方內一段時間後,海洋深層濃縮物會導致皮膚理療配方變質、不穩定及崩解。因此,本發明之纖維膜浸潤於該第二劑再浸潤於該第一劑後,敷貼於患部表面,在完成浸潤後10天內,較佳為9天、8天、7天、6天、5天、4天、3天、2天、1天內使用完畢,最佳為12小時、6小時、3小時、2小時、1小時內。 However, after the deep-sea concentrate is mixed into the skin treatment formula for a period of time, the deep-sea concentrate will cause the skin treatment formula to deteriorate, become unstable and disintegrate. Therefore, after the fiber membrane of the present invention is soaked in the second agent and then in the first agent, it is applied to the surface of the affected area within 10 days after the infiltration is completed, preferably 9 days, 8 days, 7 days, and 6 days , 5 days, 4 days, 3 days, 2 days, 1 day after use, the best is within 12 hours, 6 hours, 3 hours, 2 hours, 1 hour.
海洋深層濃縮物在混合至皮膚用理療配方後,僅經過10天,皮膚用理療配方會明顯變質。此外,海洋深層濃縮物會使皮膚用理療配方產生不明的沉澱物及浮游物,顯示海洋深層濃縮物若是混合至皮膚用理療配方內一段時間,其離子會與成分產生化學變化,降低原有皮膚用理療配方對肌膚的效果,甚至產生可能有害肌膚衍生物。 After mixing the deep ocean concentrate into the skin treatment formula, the skin treatment formula will deteriorate significantly after only 10 days. In addition, the deep-sea concentrate will produce unidentified sediments and floats in the skin treatment formula, which shows that if the deep-sea concentrate is mixed into the skin treatment formula for a period of time, its ions and ingredients will undergo chemical changes, reducing the original skin The effect of physiotherapy formula on the skin may even produce derivatives that may be harmful to the skin.
纖維膜浸潤的方式並無特限制,可使用一般的方法,例如,將纖維膜浸潤於裝有皮膚理療配方的保鮮膜袋裡,再將海洋深層濃縮物加入所述保鮮膜袋裡,使纖維膜浸潤於海洋深層濃縮物中。纖維膜浸潤於皮膚理療配方浸潤的時間並無特限制,但因為在纖維膜浸潤於海洋深層濃縮物後必須盡快使用以避免皮膚用理療配方品質惡化,所以纖維膜浸潤於海洋深層濃縮物的時間不宜過長,通常為15分鐘內,較佳為14、13、12、11、10、9、8、7、6、5、4、3分鐘內,最佳為10分鐘內。浸潤纖維膜放置的時間也不宜過長,通常為15分鐘內敷貼於患部表面,較佳為14、13、12、11、10、9、8、7、6、5、4、3分鐘內,最佳為10分鐘內。在浸潤纖維膜敷貼於患部表面後,也需要盡快施用導入儀於浸潤纖維膜上,通常為15分鐘內將導入儀施於浸潤纖維膜上,較佳為14、13、12、11、10、9、8、7、6、5、4、3分鐘內,最佳為10分鐘內。 There are no special restrictions on the way of fiber membrane infiltration, and general methods can be used. For example, the fiber membrane is soaked in a plastic wrap bag containing skin physiotherapy formula, and then the deep ocean concentrate is added to the plastic wrap bag to make the fiber The membrane is immersed in the deep ocean concentrate. There is no special restriction on the time the fiber membrane is soaked in the skin physiotherapy formula, but because it must be used as soon as possible after the fiber membrane is immersed in the deep ocean concentrate to avoid deterioration of the quality of the skin physiotherapy formula, the time for the fiber membrane to soak into the deep ocean concentrate It should not be too long, usually within 15 minutes, preferably within 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3 minutes, and most preferably within 10 minutes. The infiltration fiber membrane should not be placed for too long. It is usually applied to the surface of the affected area within 15 minutes, preferably within 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, and 3 minutes. , The best is within 10 minutes. After the infiltrated fiber membrane is applied to the surface of the affected area, it is also necessary to apply the introducer to the infiltrated fiber membrane as soon as possible, usually within 15 minutes, apply the introducer to the infiltrated fiber membrane, preferably 14, 13, 12, 11, 10 , 9, 8, 7, 6, 5, 4, 3 minutes, preferably within 10 minutes.
如上所述,該浸潤纖維膜必須儘快敷於患部,並儘快使用導入儀導入,以避免皮膚用理療配方的品質變化。 As mentioned above, the infiltrating fiber membrane must be applied to the affected area as soon as possible, and introduced as soon as possible with the introduction device to avoid changes in the quality of the skin physiotherapy formula.
在纖維膜浸潤於皮膚用理療配方與海洋深層濃縮物後,該海洋深層濃縮物會混合於該皮膚理療配方,並可馬上產生相轉移,使保養品的分子變小,並搭配導入儀使用讓海洋深層濃縮物與皮膚理療配方的混合物容易穿透皮脂膜,到達真皮層。 After the fiber membrane is infiltrated in the skin physiotherapy formula and the deep ocean concentrate, the deep ocean concentrate will be mixed with the skin physiotherapy formula, and can immediately produce phase transfer to make the molecules of the skin care products smaller, and use it with the introduction device. The mixture of deep ocean concentrate and skin treatment formula easily penetrates the sebum membrane and reaches the dermis.
【實施例】[Example]
本實施例之使用方法根據纖維膜尺寸,使用每平方公分 0.4克的皮膚理療配方浸潤纖維膜,再使用每平方公分0.4克的海洋深層濃縮物浸潤纖維膜。並於浸潤纖維膜表面施用導入儀,導入儀每平方公分施用之電流為0.1mA~0.8mA,每平方公分施用之時間為15~30秒。 The method of use in this embodiment is based on the size of the fiber membrane, using 0.4 g per square centimeter of skin physiotherapy formula to infiltrate the fiber membrane, and then use 0.4 g per square centimeter of deep ocean concentrate to infiltrate the fiber membrane. And apply the introduction device on the surface of the infiltrated fiber membrane, the current applied by the introduction device is 0.1mA~0.8mA per square centimeter, and the application time per square centimeter is 15-30 seconds.
實施例4. 56人臉部測試結果 Example 4. 56 human face test results
測試對象為20-85歲,想改善臉部外貌者,女37人,男19人,測試者年齡請參閱表一。 The test subjects are 20-85 years old who want to improve their facial appearance. There are 37 women and 19 men. Please refer to Table 1 for the age of the test subjects.
實施方式:將纖維膜放入裝有皮膚用理療配方的保鮮袋中,再將海洋深層濃縮物倒入上述的保鮮膜中,使纖維膜先浸潤於皮膚用理療配方再浸潤於海洋深層濃縮物,得到一浸潤纖維膜。此時該浸潤纖維膜含有海洋深層濃縮物與皮膚理療配方的混合物,其中該海洋深層濃縮物的有效濃度至少大於或等於1.25(v/v)%。再將浸潤纖維膜取出後立即敷貼於臉部表面上,再使用導入儀於該浸潤纖維膜上,該導入儀施用之電流為根據纖維膜大小改變電流,每平方公分施用電流0.1~0.8mA,施作時間為患部纖維膜15~30秒/cm2。 Implementation mode: Put the fiber membrane into a fresh-keeping bag containing the skin physiotherapy formula, and then pour the deep sea concentrate into the above-mentioned fresh-keeping film, so that the fiber membrane is first soaked in the skin physiotherapy formula and then in the deep sea concentrate , Get an infiltrated fiber membrane. At this time, the infiltrated fiber membrane contains a mixture of deep sea concentrate and skin physiotherapy formula, wherein the effective concentration of the deep sea concentrate is at least greater than or equal to 1.25 (v/v)%. Then take out the infiltrated fiber membrane and apply it on the face immediately, and then use the introducer on the infiltrated fiber membrane. The current applied by the introducer is to change the current according to the size of the fiber membrane, and the current is 0.1~0.8mA per square centimeter , The application time is 15-30 seconds/cm 2 of the fibrous membrane of the affected area.
其結果請參閱表二、表三以及第2~4圖。其中於實施後,改善臉部細紋,以及改善就有技術需要以侵入性治療才能改善的「眼袋、眼尾下垂、魚尾紋、眼皮下垂、眉心紋、法令紋、木偶紋、下顎線條、雙下巴、頸紋、黑眼圈、痘疤」等樣貌問題。 For the results, please refer to Table 2, Table 3 and Figures 2 to 4. Among them, after implementation, to improve facial fine lines, as well as to improve the "eye bags, drooping eye tails, crow's feet, eyelid drooping, eyebrow lines, nasolabial lines, marionette lines, jaw lines, and double chins" that require invasive treatment to improve. , Neck wrinkles, dark circles, acne scars" and other appearance problems.
第2A圖為使用本發明方法前的眼部,第2B圖為使用本發明方法後的眼部變化,第2C圖為使用本發明方法後一天的眼部變化。第2B圖中,眼周細紋、眼袋、眼尾下垂、魚尾紋、眼皮下垂、眉心紋皆已經有改善。第2C圖中,眼周細紋、眼袋、眼尾下垂、魚尾紋、眼皮下垂、眉心紋更有進一步改善。 Figure 2A is the eye before using the method of the present invention, Figure 2B is the eye change after using the method of the present invention, and Figure 2C is the eye change one day after using the method of the present invention. In Figure 2B, fine lines around the eyes, eye bags, drooping eye tails, crow's feet, drooping eyelids, and brow lines have all been improved. In Figure 2C, fine lines around the eyes, bags under the eyes, drooping eye tails, crow's feet, drooping eyelids, and brow lines are further improved.
第2D圖為使用本發明方法前的眼部,第2E圖為使用本發明方法後的眼部變化,第2F圖為使用本發明方法後一天的眼部變化。第2E圖中,眼周細紋、眼袋、眼尾下垂、魚尾紋、眼皮下垂、眉心紋皆已經有改善。第2F圖中,眼周細紋、眼袋、眼尾下垂、魚尾紋、眼皮下垂、眉心紋更有進一步改善。 Figure 2D is the eye before using the method of the present invention, Figure 2E is the eye change after using the method of the present invention, and Figure 2F is the eye change one day after using the method of the present invention. In Figure 2E, the fine lines around the eyes, eye bags, drooping eye tails, crow's feet, drooping eyelids, and brow lines have all been improved. In Figure 2F, fine lines around the eyes, eye bags, drooping eye tails, crow's feet, drooping eyelids, and eyebrow lines are further improved.
第3A-3C圖顯示本發明之使用方法於整體臉部之使用前後比較圖,臉整體的變化。第3A圖為使用前,第3B圖為使用後第四天,第3C圖為使用後第五天。第3B圖細紋、眼袋、眼尾下垂、魚尾紋、眼皮下垂、眉心紋、法令紋、木偶紋、下顎線條、雙下巴、頸紋、黑眼圈皆已經有改善。第3C圖中,眼袋、眼尾下垂、下顎線條、雙下巴更是有明顯進一步改善,臉頰兩側有明顯拉提的效果。。 Figures 3A-3C show the comparison of the application method of the present invention before and after the use of the whole face, and the changes of the whole face. Picture 3A is before use, picture 3B is the fourth day after use, and picture 3C is the fifth day after use. Figure 3B Fine lines, eye bags, drooping eye tails, crow's feet, drooping eyelids, eyebrow lines, nasolabial lines, marionette lines, jaw lines, double chin, neck lines, and dark circles have all been improved. In Figure 3C, eye bags, drooping eye tails, chin lines, and double chin have been significantly improved, and both sides of the cheeks have been lifted. .
第3D、3E圖顯示本發明之使用方法於臉部之使用前後比較圖,臉整體的變化。第3D圖為使用前,第3E圖為使用後。第3E圖中,細紋、眼袋、眼尾下垂、魚尾紋、眼皮下垂、眉心紋、法令紋、木偶紋、下顎線條、雙下巴、頸紋、黑眼圈,由其是下顎線條,臉頰兩側有明顯拉提的效果。 Figures 3D and 3E show the comparison of the application method of the present invention before and after the use of the face, and the overall changes of the face. Picture 3D is before use, Picture 3E is after use. In Figure 3E, fine lines, eye bags, drooping eye tails, crow's feet, drooping eyelids, eyebrow lines, nasolabial lines, marionette lines, chin lines, double chins, neck lines, and dark circles are the lines of the chin. Obviously lifting effect.
第4A-4B圖顯示本發明之使用方法於臉部之使用前後比較圖,頸部鬆弛(即雙下巴)的變化。第4A圖為使用前,第4B圖為使用後。第4B圖中,頸部鬆弛有明顯改善,有明顯下顎拉提的效果。 Figures 4A-4B show the comparison of the application method of the present invention on the face before and after use, and the changes in the looseness of the neck (ie double chin). Picture 4A is before use, Picture 4B is after use. In Figure 4B, the neck relaxation has been significantly improved, and there is a significant effect of jaw lifting.
實施例6.導入儀 Example 6. Introduction instrument
本發明之使用方法配合導入儀使用,導入儀可使用一般市售之導入儀,較佳地,請參考第5圖導入儀的控制電路示意圖,導入儀係包含一給電裝置與一傳感器,前述給電裝置包含一外表面及一內裝;其中,前述給電裝置之外表面包含:一操作面板,其設置於前述理療儀之一側面,藉以提供一控制指令,調控前述給電裝置所輸出之一直流電,前述直流電係由不同強度與不同時間比例的正負電所組合;一傳感器連接孔,藉以外接前述傳感器,前述傳感器連接孔更具有一稳定电流侦测電路127,係電連一控制電路以及前述傳感器連接孔,用以放大一刺激電流之電壓;以及一電源輸入端,設置於前述理療儀另一側面,藉以提供前述給電裝置一電源,前述電源輸入端更具有複數安 全電路125,係電連前述控制電路以及前述電源輸入端,用以控制前述電源之不同電壓;其中,前述給電裝置之內裝具有前述控制電路,係電連前述操作面板取得前述控制指令以及前述電源輸入端取得前述電源供應,並經由前述傳感器連接孔輸出前述直流電,包含:一固定實測人體電路126,用以控制前述直流電之不同強度;以及一開關閥電路,係經由前述控制指令選擇,控制前述直流電之正負電;其中,前述傳感器係指以一電線外接前述給電裝置之前述傳感器連接孔,其具有一特定面積介面的放電端,使前述直流電經由前述傳感器輸出前述刺激電流。 The method of use of the present invention is used with a lead-in instrument. The lead-in instrument can be a general commercially available lead-in instrument. Preferably, please refer to the schematic diagram of the control circuit of the lead-in instrument in Figure 5. The lead-in instrument includes a power supply device and a sensor. The device includes an outer surface and an interior; wherein, the outer surface of the power feeding device includes: an operation panel, which is arranged on a side of the physical therapy device, so as to provide a control command to regulate a direct current output by the power feeding device, The aforementioned direct current is a combination of positive and negative electricity of different intensities and different time ratios; a sensor connection hole, through which the aforementioned sensor is connected, the aforementioned sensor connection hole has a stable
實施例7.抑制膠原蛋白流失 Example 7. Inhibition of collagen loss
請參考第6A圖、第6B圖、表三以及表四,本發明係委託工研院利用體外試管實驗研究海洋深層濃縮物抑制基質金屬蛋白酶-1(Matrix Metalloproteinase-1,MMP-1)及基質金屬蛋白酶-3(Matrix Metalloproteinase-3,MMP-3)的效能。基質金屬蛋白酶-1和基質金屬蛋白酶-3是通稱的膠原蛋白分解酶其中的兩種,為調節光老化重要因子,纖維母細胞受陽光之紫外線曝曬會引起基質金屬蛋白酶大量表現,進而降解細胞外基質(Extracellular matrix,ECM),也就是說MMP-1和MMP-3負責真皮組織中膠原蛋白的降解流失。藉此實驗證實海洋深層濃縮物具有抑制膠 原蛋白流失的功能,NNGH(N-Isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid)為基質金屬蛋白酶的失活藥物(MMP失活藥物),由第6A、6B圖實驗數據可得知,與NNGH抑制率相比(VS.NNGH),0.5%濃度的海洋深層濃縮物可相對地抑制4.92%的基質金屬蛋白酶-1活性以及抑制2.18%的基質金屬蛋白酶-3活性。1%濃度的海洋深層濃縮物可抑15.13%的基質金屬蛋白酶-1的活性以及抑制8.12%的基質金屬蛋白酶-3活性。2%濃度的海洋深層濃縮物可抑制高達23.93%的基質金屬蛋白酶-1活性以及抑制27.71%的基質金屬蛋白酶-3活性。本實驗說明海洋深層濃縮物可有效抑制基質金屬蛋白酶-1和基質金屬蛋白酶-3的酵素活性,與NNGH抑制率相比,抑制基質金屬蛋白酶-1和基質金屬蛋白酶-3活性的效果高達50%。表示海洋深層濃縮物具有抑制膠原蛋白流失的效能,促使肌膚細胞展現較佳健康狀態,有利於所有針對肌膚細胞有效之成分加成效果。 Please refer to Figure 6A, Figure 6B, Table 3 and Table 4, the present invention commissioned the Industrial Technology Research Institute to use in vitro test tube experiments to study the inhibition of matrix metalloproteinase-1 (MMP-1) and matrix by deep ocean concentrates. The potency of metalloproteinase-3 (Matrix Metalloproteinase-3, MMP-3). Matrix metalloproteinase-1 and matrix metalloproteinase-3 are two of the commonly known collagen degrading enzymes. In order to regulate the important factors of photoaging, the exposure of fibroblasts to the ultraviolet rays of the sun will cause a large amount of matrix metalloproteinases to be expressed, and then degrade the extracellular Extracellular matrix (ECM), which means that MMP-1 and MMP-3 are responsible for the degradation and loss of collagen in the dermal tissue. This experiment proves that the deep ocean concentrate has the function of inhibiting the loss of collagen. NNGH (N-Isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid) is an inactivating drug for matrix metalloproteinase (MMP inactivating drug). According to the experimental data in Figures 6A and 6B, compared with the inhibition rate of NNGH (VS.NNGH), the 0.5% concentration of deep ocean concentrate can relatively inhibit 4.92% of matrix metalloproteinase-1 activity and 2.18% of matrix metal Protease-3 activity. 1% concentration of deep ocean concentrate can inhibit 15.13% of matrix metalloproteinase-1 activity and 8.12% of matrix metalloproteinase-3 activity. A 2% concentration of deep ocean concentrate can inhibit up to 23.93% of matrix metalloproteinase-1 activity and 27.71% of matrix metalloproteinase-3 activity. This experiment shows that the deep ocean concentrate can effectively inhibit the enzyme activity of matrix metalloproteinase-1 and matrix metalloproteinase-3. Compared with the inhibition rate of NNGH, the effect of inhibiting the activity of matrix metalloproteinase-1 and matrix metalloproteinase-3 is as high as 50%. . It means that the deep ocean concentrate has the effect of inhibiting the loss of collagen, promotes skin cells to show better health, and is conducive to the addition of all effective ingredients for skin cells.
實施例8. 增加膠原蛋白分泌 Example 8. Increase collagen secretion
請參考第7圖,本實驗以0-1%濃度的海洋深層濃縮物配搭維生素C複方,顯示不同濃度的海洋深層濃縮物所分泌膠原蛋白的量。 Please refer to Figure 7. This experiment uses 0-1% deep ocean concentrate with vitamin C compound to show the amount of collagen secreted by different concentrations of deep ocean concentrate.
實施例9.電子狀態 Example 9. Electronic state
皮膚護理配方與海洋深層濃縮物混和後,產生微粒胞體表面電極及其電荷(圖未示),根據其比例設計直流電正電流及負電流施用的時間比例。 After the skin care formula is mixed with the deep sea concentrate, the surface electrodes of the microsomes and their charges (not shown) are generated, and the time ratio of the direct current positive current and the negative current application is designed according to the ratio.
發明所揭露的所有特徵應可以任何結合方式實現。本發明所揭露的每一特徵應可以相同、均等或相似目的的取代物所取代。因此,除非有明確的指定,否則所揭露的每一個特徵僅僅只是均等物或相似特徵 的一個種類的一實施例。 All the features disclosed in the invention can be realized in any combination. Each feature disclosed in the present invention should be replaced by substitutes with the same, equal or similar purpose. Therefore, unless explicitly specified, each feature disclosed is merely an example of a category of equivalents or similar features.
Claims (8)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW107122672A TWI712425B (en) | 2018-06-29 | 2018-06-29 | Skin physiotherapy formula of deep sea water concentrate for mature skin appearance improvement and the use thereof |
| CN201811563016.8A CN110652472B (en) | 2018-06-29 | 2018-12-20 | Method for improving aging appearance of human body by using skin physiotherapy formula of deep sea concentrate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW107122672A TWI712425B (en) | 2018-06-29 | 2018-06-29 | Skin physiotherapy formula of deep sea water concentrate for mature skin appearance improvement and the use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202000178A TW202000178A (en) | 2020-01-01 |
| TWI712425B true TWI712425B (en) | 2020-12-11 |
Family
ID=69028811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW107122672A TWI712425B (en) | 2018-06-29 | 2018-06-29 | Skin physiotherapy formula of deep sea water concentrate for mature skin appearance improvement and the use thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN110652472B (en) |
| TW (1) | TWI712425B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114425057B (en) * | 2020-10-15 | 2024-10-11 | 苏珍仪 | Nursing composition and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09169617A (en) * | 1995-12-22 | 1997-06-30 | Japan Giyaruzu:Kk | Makeup mask |
| CN104602755A (en) * | 2012-02-08 | 2015-05-06 | 德尔玛梦想集团有限公司 | Transdermal delivery device |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE419897T1 (en) * | 2001-10-24 | 2009-01-15 | Power Paper Ltd | DEVICE FOR THE CONTROLLED DELIVERY OF AN ACTIVE SUBSTANCE INTO THE SKIN |
| KR100507453B1 (en) * | 2003-06-17 | 2005-08-08 | (주)로츠 | Method and apparatus for controlling the power of a skin care device, and handable skin care device using the same |
| TW200927182A (en) * | 2007-12-24 | 2009-07-01 | Stone & Resource Ind R & D Ct | Essence concentrate and lotion using deep seawater as its carrier |
| US20160089308A1 (en) * | 2014-09-29 | 2016-03-31 | Elc Management Llc | Targeted And Individualized Delivery Of Skincare Treatments With Micro-Current In A Mask Or Patch Form |
-
2018
- 2018-06-29 TW TW107122672A patent/TWI712425B/en active
- 2018-12-20 CN CN201811563016.8A patent/CN110652472B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09169617A (en) * | 1995-12-22 | 1997-06-30 | Japan Giyaruzu:Kk | Makeup mask |
| CN104602755A (en) * | 2012-02-08 | 2015-05-06 | 德尔玛梦想集团有限公司 | Transdermal delivery device |
Non-Patent Citations (4)
| Title |
|---|
| SK Kim,et al."Sea Water and Sea Mud Cosmeceutical Applications",In book: Marine Cosmeceuticals, pp.241-256, December 2011. * |
| SK Kim,et al."Sea Water and Sea Mud Cosmeceutical Applications",In book: Marine Cosmeceuticals, pp.241-256, December 2011.。 |
| 網路資料--"美人養成學院-導入儀到底有沒有必要買?解析三大種類導入儀讓你不花冤望錢!",2017/07/09,(https://www.beautywish.com.tw /index.php? route=journal2/ blog /post &journal_blog_post_id=412). * |
| 網路資料--"美人養成學院-導入儀到底有沒有必要買?解析三大種類導入儀讓你不花冤望錢!",2017/07/09,(https://www.beautywish.com.tw /index.php? route=journal2/ blog /post &journal_blog_post_id=412).。 |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202000178A (en) | 2020-01-01 |
| CN110652472B (en) | 2023-04-07 |
| CN110652472A (en) | 2020-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101100632B1 (en) | Apparatus and topical compositions for the treatment of acne and acne using electrochemically generated zinc ions | |
| KR101100630B1 (en) | Method for producing a composition comprising microparticles for administering electricity to a human | |
| US20090210036A1 (en) | Laser ionization therapy system and method | |
| CN105030622B (en) | A kind of lightening compositions and preparation method thereof | |
| CN106265415A (en) | A kind of have moisturizing and the skin care compositions of after-sun restorative function and application thereof | |
| TWI702051B (en) | Efficient nano spot lightening, brightening, moisturizing activator and its preparation method | |
| TWI712425B (en) | Skin physiotherapy formula of deep sea water concentrate for mature skin appearance improvement and the use thereof | |
| CN107496307A (en) | A kind of whitening and moisturizing facial mask | |
| JP2008173230A (en) | Facial beauty treatment method | |
| CN107397531A (en) | A kind of intelligent facial mask of cell phone application control | |
| CN109077940A (en) | A kind of beauty mask and preparation method thereof of electrolysis water preparation | |
| CN201906178U (en) | Foot bathing device with low-frequency pulse | |
| CN102670420A (en) | Negative ion mask | |
| CN102949302A (en) | Negative ion cell activating solution | |
| CN112402788A (en) | A bioelectrical stimulation meridian and stimulation device | |
| KR20100003074A (en) | A functional salt and a method of preparing the same | |
| CN106726854A (en) | It is a kind of to be adapted to the essential oil face pack that water deficient skin is used | |
| KR100500100B1 (en) | Method for controlling ion injector into skin having improved ion-transmission effect, and ion injector adopting the same | |
| CN110433098A (en) | Skin care lotion capable of releasing negative ions, energy elements and magnetic effects and its application | |
| CN108567631A (en) | A kind of self-control mulberry leaf eye mask | |
| CN120514622A (en) | Formula and production process of a beauty and skin care product and its application | |
| KR20060081174A (en) | Skin massage kit containing crystalline inorganic mineral and skin massage method using crystalline inorganic mineral | |
| CA2464976A1 (en) | Superfine aqueous dispersion of noble metal for head massage | |
| CN116650388A (en) | Eye spray rich in marine elements and preparation method thereof | |
| CN101015722A (en) | Biological negative electricity channels-collaterals acupoint health care therapeutic method and system |